|Registered name:||Summit Therapeutics plc|
|Country of incorporation:||England & Wales|
|Main country of operation:||United Kingdom|
|Registered address:||136a Eastern Avenue
|Company Secretary:||Melissa Strange, FCCA|
Summit Therapeutics plc is subject to the UK City Code on Takeovers and Mergers.
The Company’s current articles of association can be viewed here:
Articles of Association (pdf 233KB)
The Company’s Admission Document to AIM, a market of the London Stock Exchange is available:
Admission Document (pdf)
Please note this document was issued more than twelve years ago and is accordingly substantially out of date. For more accurate and up-to-date information, please refer to other sections of this website, the latest Annual Report, our filings with the US Securities & Exchange Commission, recent regulatory announcements and other such information sources on the web.